Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FDM46
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $102,057
Award facts
- Contract value 100% obligated
- $102,057.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $102,057.47 by the Defense Logistics Agency (DLA) for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, represents a continuation of the company's substantial pharmaceutical supply relationship with the federal government. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market leveraging its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Xtandi, an oncology treatment, represents the type of specialized pharmaceutical product covered under this IDC umbrella. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites, with this particular order fulfilling medical supply needs for the military health system.
Quick answers
Who was awarded contract SPE2DB25FDM46?
SPE2DB25FDM46 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FDM46 worth?
The government has obligated $102,057 on SPE2DB25FDM46.
Is contract SPE2DB25FDM46 an order under another contract?
Yes. SPE2DB25FDM46 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM46 competed?
The extent of competition for SPE2DB25FDM46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award